Flash pulmonary edema

Progress in Cardiovascular Diseases
Stefano F RimoldiFranz Messerli

Abstract

Flash pulmonary edema (FPE) is a general clinical term used to describe a particularly dramatic form of acute decompensated heart failure. Well-established risk factors for heart failure such as hypertension, coronary ischemia, valvular heart disease, and diastolic dysfunction are associated with acute decompensated heart failure as well as with FPE. However, endothelial dysfunction possibly secondary to an excessive activity of renin-angiotensin-aldosterone system, impaired nitric oxide synthesis, increased endothelin levels, and/or excessive circulating catecholamines may cause excessive pulmonary capillary permeability and facilitate FPE formation. Renal artery stenosis particularly when bilateral has been identified has a common cause of FPE. Lack of diurnal variation in blood pressure and a widened pulse pressure have been identified as risk factors for FPE. This review is an attempt to delineate clinical and pathophysiological mechanisms responsible for FPE and to distinguish pathophysiologic, clinical, and therapeutic aspects of FPE from those of acute decompensated heart failure.

References

Jan 1, 1975·British Heart Journal·H D Tandon, J Kasturi
Oct 1, 1992·International Journal of Sports Medicine·P H HackettB D Levine
Mar 1, 1968·The British Journal of Radiology·B E HeardD Gleason
Apr 1, 1984·Southern Medical Journal·B A ChaudharyW A Speir
Jul 1, 1982·Chest·B A ChaudharyW A Speir
Oct 1, 1995·The Journal of Clinical Investigation·V K SomersF M Abboud
Dec 1, 1995·Journal of the American College of Cardiology·R S VasanD Levy
Sep 1, 1994·Japanese Circulation Journal·O YamanakaH Yamaguchi
Feb 1, 1994·Medicine and Science in Sports and Exercise·J A Krasney
Mar 1, 1993·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J R Diamond
Mar 7, 1996·The New England Journal of Medicine·U ScherrerP Bärtsch
Mar 1, 1997·American Journal of Respiratory and Critical Care Medicine·S R HopkinsJ B West
Aug 11, 1997·Archives of Internal Medicine·T YoungJ Skatrud
May 25, 1999·Circulation·C SartoriU Scherrer
Nov 11, 1999·American Journal of Respiratory and Critical Care Medicine·E C FletcherG Bao
Apr 19, 2000·JAMA : the Journal of the American Medical Association·F J NietoT G Pickering
Apr 25, 2000·Hypertension·M J CarvalhoA Falcao De Freitas
May 11, 2000·The New England Journal of Medicine·P E PeppardJ Skatrud
May 12, 2000·Journal of the American College of Cardiology·J S GottdienerR C Boineau
Jan 4, 2001·The New England Journal of Medicine·S K GandhiW C Little
Jul 27, 2001·Circulation·L ZhaoM R Wilkins
Aug 25, 2001·The New England Journal of Medicine·S YusufUNKNOWN Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
Feb 7, 2003·Current Pharmaceutical Design·Richard P Marshall
Sep 25, 2003·Metabolism: Clinical and Experimental·Norman L M WongJoseph K C Tsui
Oct 9, 2003·JAMA : the Journal of the American Medical Association·Abu S M ShamsuzzamanVirend K Somers
Dec 10, 2003·Journal of the American College of Cardiology·Carmel M McEnieryIan B Wilkinson
Feb 11, 2004·Chest·Brian K Gehlbach, Eugene Geppert

❮ Previous
Next ❯

Citations

Mar 17, 2011·European Heart Journal·Franz H MesserliPeter Sleight
Jan 21, 2012·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Constantina ChrysochouPhilip A Kalra
Dec 25, 2013·European Heart Journal·Stefano F RimoldiFranz H Messerli
Oct 1, 2013·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·James RitchiePhilip A Kalra
Sep 5, 2012·The American Journal of Emergency Medicine·Joaquín Valle AlonsoCarmen Navarro
Jun 9, 2012·Mayo Clinic Proceedings·Muaz M AbudiabWilliam K Freeman
Aug 12, 2015·European Heart Journal·Stefano F RimoldiUrs Scherrer
Oct 19, 2016·Clinical and Experimental Emergency Medicine·Dick C Kuo, W Frank Peacock
Apr 8, 2016·Cardiovascular Intervention and Therapeutics·Osami KawaradaHisao Ogawa
Feb 24, 2015·PPAR Research·Elizabeth P Moran, Jian-Xing Ma
Feb 26, 2015·Clinical Kidney Journal·Wei ChenGraciela O DeBoccardo
Sep 30, 2016·Clinical Kidney Journal·Reem Daloul, Aubrey R Morrison
Feb 6, 2017·Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine·Naman AgrawalNayer Jamshed
May 23, 2019·Current Opinion in Critical Care·David H Ingbar
Jan 21, 2020·QJM : Monthly Journal of the Association of Physicians·Yisik Kim, Sun Hwa Lee
Jan 22, 2011·Blood Pressure·Franz H Messerli, Sripal Bangalore
Apr 30, 2013·Current Opinion in Critical Care·Philippe Vignon
Jun 16, 2017·Turkish Journal of Emergency Medicine·Tolga CimenEkrem Yeter
May 11, 2018·International Heart Journal·Teppei FujitaJunya Ako
Sep 12, 2020·Respiratory Medicine Case Reports·Ali Ahmad
Feb 11, 2021·BMJ Case Reports·Prawal ShrimalAbhinav Bansal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Related Papers

Progress in Cardiovascular Diseases
Constantina Chrysochou, Philip A Kalra
The New England Journal of Medicine
ASTRAL InvestigatorsJohn Scoble
© 2022 Meta ULC. All rights reserved